Side-by-side comparison of AI visibility scores, market position, and capabilities
Workday (NASDAQ: WDAY) cloud FP&A platform acquired for $1.55B serving 6,000+ organizations with collaborative budgeting and scenario modeling; competing with Anaplan and OneStream for enterprise finance planning.
Workday Adaptive Planning is Workday's (NASDAQ: WDAY) cloud-based financial planning and analysis (FP&A) platform — acquired by Workday in 2018 for $1.55 billion — providing collaborative budgeting, forecasting, scenario modeling, and management reporting for finance teams at mid-market and enterprise organizations. Part of Workday's $8.4 billion revenue platform (fiscal year 2025), Adaptive Planning serves finance and FP&A professionals at 6,000+ organizations including Netflix, The Salvation Army, and Boston Scientific for planning workflows that replace Excel-based budgeting models with connected, version-controlled plans that multiple users can update simultaneously.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.